Benzinga - Wed, 17 Mar 2021 07:11:27 -0400
Benzinga - Wed, 10 Feb 2021 06:16:46 -0400
Benzinga - Tue, 09 Feb 2021 13:13:04 -0400
Benzinga - Tue, 09 Feb 2021 06:14:44 -0400
Benzinga - Mon, 08 Feb 2021 13:29:53 -0400
Benzinga - Mon, 08 Feb 2021 11:34:01 -0400
Benzinga - Fri, 05 Feb 2021 12:06:36 -0400
Benzinga - Tue, 26 Jan 2021 11:10:59 -0400
load more
Summit Therapeutics Inc is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of medicines for indications for which there inadequate or no therapies. It also conducts clinical programs focused on the genetic disease Cuchenne muscular dystrohy and the infectious disease Clostridium difficile infection. The company has drug development segment. All assets of the company are located in the United Kingdom.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-01
REV
Q4 2020Est.ActualSurprise
EPS-0.180
REV185.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SMMTSummit Therapeutics0%466.8M

Summit Therapeutics Company Questions & Answers

Q

How do I buy Summit Therapeutics (SMMT) stock?

A

You can purchase shares of Summit Therapeutics (NASDAQ: SMMT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Summit Therapeutics's (SMMT) main competitors?

A

There are no as such competitors for Summit Therapeutics.

Q

What is the target price for Summit Therapeutics?

A

The latest price target for Summit Therapeutics (NASDAQ: SMMT) was reported by HC Wainwright & Co. on 2020-11-18. The analyst firm set a price target for 0.00 expecting SMMT to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Q

How much is Summit Therapeutics (SMMT) stock ?

A

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $5.63 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Summit Therapeutics (SMMT) dividend?

A

There are no upcoming dividends for Summit Therapeutics.

Q

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

A
Summit Therapeutics’s Q1 earnings are confirmed after-market from now on June 1, 2021.
Q

When is the upcoming split for SMMT?

A

There is no upcoming split for Summit Therapeutics.